Literature DB >> 20865305

Substance P enhances Th17 phenotype in individuals with generalized anxiety disorder: an event resistant to glucocorticoid inhibition.

Priscila O Barros1, Thais B Ferreira, Morgana M M Vieira, Carla Renata M Almeida, Carlos Fernando Araújo-Lima, Renato G Silva-Filho, Joana Hygino, Regis M Andrade, Arnaldo F Andrade, Cleonice A Bento.   

Abstract

Our objective was to evaluate the effect of stress-related dose of substance P (SP) on the in vitro proliferation and cytokine production in polyclonally activated T cells from healthy individuals or individuals with generalized anxiety disorder (GAD). Our results demonstrated that cell cultures from GAD group proliferated less following T cell activation, as compared with control group. The addition of SP enhanced, while the glucocorticoid (GC) reduced, the proliferative response in activated cell cultures from healthy but not from GAD individuals. The cytokine profile in GAD individuals revealed Th1 and Th2 deficiencies were associated with dominate Th17 phenotype which was enhanced by SP. Differently from control, the production of Th17 cytokines in GAD individuals was not affected by GC. In conclusion, our results show that complex T cell functional dysregulation in GAD individuals is significantly amplified by SP. These immune abnormalities can have impact in increasing the susceptibility to infectious diseases and inflammatory/autoimmune disorders in anxious individuals.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20865305     DOI: 10.1007/s10875-010-9466-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  89 in total

Review 1.  The corticosteroid receptor hypothesis of depression.

Authors:  F Holsboer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

Review 2.  PTSD is associated with an excess of inflammatory immune activities.

Authors:  Jessica M Gill; Leo Saligan; Stephanie Woods; Gayle Page
Journal:  Perspect Psychiatr Care       Date:  2009-10       Impact factor: 2.186

3.  Impairment of several immune functions in anxious women.

Authors:  Lorena Arranz; Noelia Guayerbas; Mónica De la Fuente
Journal:  J Psychosom Res       Date:  2007-01       Impact factor: 3.006

4.  Phenotype of blood lymphocytes in PTSD suggests chronic immune activation.

Authors:  S N Wilson; B van der Kolk; J Burbridge; R Fisler; R Kradin
Journal:  Psychosomatics       Date:  1999 May-Jun       Impact factor: 2.386

Review 5.  APC-derived cytokines and T cell polarization in autoimmune inflammation.

Authors:  Ilona Gutcher; Burkhard Becher
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 6.  The role of substance P in inflammatory disease.

Authors:  Terence M O'Connor; Joseph O'Connell; Darren I O'Brien; Triona Goode; Charles P Bredin; Fergus Shanahan
Journal:  J Cell Physiol       Date:  2004-11       Impact factor: 6.384

7.  The Beck Anxiety Inventory-Trait (BAIT): a measure of dispositional anxiety not contaminated by dispositional depression.

Authors:  Paul M Kohn; Ludmila Kantor; Teresa L DeCicco; Aaron T Beck
Journal:  J Pers Assess       Date:  2008-09

8.  Human lymphocytes express substance P and its receptor.

Authors:  J P Lai; S D Douglas; W Z Ho
Journal:  J Neuroimmunol       Date:  1998-06-01       Impact factor: 3.478

Review 9.  Substance P and its receptors -- a potential target for novel medicines in malignant brain tumour therapies (mini-review).

Authors:  Marzena Łazarczyk; Ewa Matyja; Andrzej Lipkowski
Journal:  Folia Neuropathol       Date:  2007       Impact factor: 2.038

10.  Reduced anxiety level by therapeutic interventions and cell-mediated immunity in panic disorder patients.

Authors:  Kyung Bong Koh; Youngjoon Lee
Journal:  Psychother Psychosom       Date:  2004 Sep-Oct       Impact factor: 17.659

View more
  5 in total

Review 1.  The role of Th17 cells in the pathophysiology of pregnancy and perinatal mood and anxiety disorders.

Authors:  Lauren M Osborne; Amitoj Brar; Sabra L Klein
Journal:  Brain Behav Immun       Date:  2018-11-19       Impact factor: 7.217

Review 2.  Botulinum Toxin Use for Modulating Neuroimmune Cutaneous Activity in Psoriasis.

Authors:  Marius Nicolae Popescu; Cristina Beiu; Mădălina Gabriela Iliescu; Mara Mădălina Mihai; Liliana Gabriela Popa; Ana Maria Alexandra Stănescu; Mihai Berteanu
Journal:  Medicina (Kaunas)       Date:  2022-06-16       Impact factor: 2.948

Review 3.  Neuropeptide substance P and the immune response.

Authors:  Alireza Mashaghi; Anna Marmalidou; Mohsen Tehrani; Peter M Grace; Charalabos Pothoulakis; Reza Dana
Journal:  Cell Mol Life Sci       Date:  2016-06-17       Impact factor: 9.261

Review 4.  The Role of Nociceptive Neurons in the Pathogenesis of Psoriasis.

Authors:  Xuan Zhang; Yanling He
Journal:  Front Immunol       Date:  2020-09-29       Impact factor: 7.561

Review 5.  Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.

Authors:  Giordani Rodrigues Dos Passos; Douglas Kazutoshi Sato; Jefferson Becker; Kazuo Fujihara
Journal:  Mediators Inflamm       Date:  2016-01-28       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.